Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
Public ClinicalTrials.gov record NCT00498602. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase Iia, Multicenter, Randomized, Third-party Unblinded, Adjuvant And Placebo-controlled, Multiple Ascending Dose, Safety, Tolerability, And Immunogenicity Trial Of Acc-001 And Qs-21 Adjuvant In Subjects With Mild To Moderate Alzheimers Disease
Study identification
- NCT ID
- NCT00498602
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Interventions
- ACC-001 + QS-21 Biological
- QS-21 Biological
- Diluent: Phosphate Buffered Saline Other
- ACC-001 Biological
Biological · Other
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2007
- Primary completion
- Jan 31, 2013
- Completion
- Jan 31, 2013
- Last update posted
- Dec 31, 2015
2007 – 2013
United States locations
- U.S. sites
- 27
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Alzheimer's Institute | Phoenix | Arizona | 85006 | — |
| Banner Good Samaritan Medical Center | Phoenix | Arizona | 85006 | — |
| Banner Boswell Medical Center | Sun City | Arizona | 85351 | — |
| Sun Health Research Institute | Sun City | Arizona | 85351 | — |
| University of California - San Francisco | San Francisco | California | 94117 | — |
| University of California, San Francisco | San Francisco | California | 94117 | — |
| University of California, San Francisco | San Francisco | California | 94118 | — |
| University of California, San Francisco | San Francisco | California | 94158 | — |
| General Clinical Research Center | New Haven | Connecticut | 06509 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06510 | — |
| Yale-New Haven Hospital | New Haven | Connecticut | 06511 | — |
| General Clinical Research Center | Washington D.C. | District of Columbia | 20007 | — |
| GUMC | Washington D.C. | District of Columbia | 20057 | — |
| MD Clinical | Hallandale | Florida | 33009 | — |
| Palm Beach Neurology - Premiere Research Institute | West Palm Beach | Florida | 33407 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Barnes-Jewish Hospital | St Louis | Missouri | 63108 | — |
| Washington University School of Medicine | St Louis | Missouri | 63108 | — |
| Barrnes-Jewish Hospital at Washington University | St Louis | Missouri | 63110 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Memory Enhancement Center of America, Inc. | Eatontown | New Jersey | 07724 | — |
| Pharmcare USA | Edison | New Jersey | 08837 | — |
| Columbia Univ/Taub Institute Irving Ctr for Clinical Researc | New York | New York | 10032 | — |
| CUMC Research Pharmacy | New York | New York | 10032 | — |
| Butler Hospital | Providence | Rhode Island | 02906 | — |
| The Memory Clinic | Bennington | Vermont | 05201 | — |
| The Pharmacy | Bennington | Vermont | 05201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00498602, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 31, 2015 · Synced Jul 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00498602 live on ClinicalTrials.gov.